Used primarily as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of receptor-targeted drugs, including those with potential antipsychotic, antidepressant, or analgesic effects. The fluorinated benzyl group enhances binding affinity and metabolic stability, making it valuable in medicinal chemistry for optimizing drug candidates. It is also employed in research settings to explore structure-activity relationships in piperidine-based bioactive molecules.